Ctxr sec filings

WebApr 6, 2024 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. WebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings...

CTXR Citius Pharmaceuticals Inc. SEC Filings MarketWatch

WebMay 13, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 13 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebFind the latest SEC Filings data for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Citius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings … iras directive to pay https://ameritech-intl.com

Yahoo Finance - Stock Market Live, Quotes, Business & Finance …

WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc WebCitius Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the CTXR U.S. Securities and Exchange Commission reporting information. WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … iras direct credit refund

Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K …

Category:SG Americas Securities LLC Takes $108,000 Position in Citius ...

Tags:Ctxr sec filings

Ctxr sec filings

CTXR 13F Hedge Fund and Asset Management Owners

WebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … WebSEC Filings for Citius Pharmaceuticals Inc (CTXR) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If …

Ctxr sec filings

Did you know?

WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebInstitutional Ownership and Shareholders Citius Pharmaceuticals Inc (US:CTXR) has 94 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). …

WebThis table shows the interest rate that must be paid by a short seller of US:CTXR to the lender of that security. This fee is shown as an annual percentage rate (APR). Lenders are funds or individuals that own the … WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter

WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to... WebJan 15, 2013 · Ticker: CTXR CIK: 1506251 Form Type: 10-K Annual Report Accession Number: 0001185185-13-000090 Submitted to the SEC: Tue Jan 15 2013 1:09:25 PM EST Accepted by the SEC: Tue Jan 15 2013 Period: Sunday, September 30, 2012 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark …

WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024

WebApr 6, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-018307 Submitted to the SEC: Wed Apr 06 2024 8:11:08 AM EST Accepted by the SEC: Wed Apr 06 2024 Period: Wednesday, April 6, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … order a nameplateWebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio. order a natwest cheque bookWebApr 3, 2024 · ctxr The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 … iras directly in connectionWebView 13F filing holders of Citius Pharmaceuticals Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. WhaleWisdom. 13F Data. Latest 13F Filings; 13F Heat Map; 13F Trend Charts; 13F Stats; Stock 13F Stats; Stock Earnings and Events Calendar ... Funds Holding CTXR (via 13F filings) order a nationwide card readerWebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … order a natwest cheque book onlineWebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024 order a natwest card readerWebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. order a natwest debit card